http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2020147852-A1

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_15c71ca08224228efb984614e12df9a7
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_e4d6f303f51487297fb3525576fd8fc7
classificationCPCAdditional http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07B2200-13
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-24
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07J43-003
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07J43-00
filingDate 2020-01-19^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_96a5de7ff75478d49b388a5aeed36c16
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_bbb953c1720113b5a6f5acade58fdaab
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_7b73ba7f4df6aff59ab097b2bfd3b287
publicationDate 2020-07-23^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber WO-2020147852-A1
titleOfInvention Crystal forms of antidepressant drug sage-217 and preparation method therefor
abstract The present application relates to crystal form 04, crystal form 06, crystal form D-1, and crystal form D-2 of an antidepressant drug SAGE-217 and a preparation method therefor and a pharmaceutical composition containing same. The XRPD of crystal form 04 has characteristic peaks at 2theta values of 11.6±0.2°, 13.5±0.2°, 16.2±0.2°, 16.5±0.2°, and 23.2±0.2°; the XRPD of crystal form 06 has characteristic peaks at 2theta values of 8.7±0.2°, 10.0±0.2°, 13.2±0.2°, 15.0±0.2°, 15.8±0.2°, and 17.3±0.2°; the XRPD of crystal form D-1 has characteristic peaks at 2theta values of 7.2±0.2°, 8.6±0.2°, 13.3±0.2°, 19.6±0.2°, and 23.0±0.2°; and the XRPD of crystal form D-2 has characteristic peaks at 2theta values of 7.3±0.2°, 8.6±0.2°, 13.4±0.2°, 19.7±0.2°, and 23.3±0.2°. The new crystal forms provided by the present application have good stability, and provide more choices for drug development.
priorityDate 2019-01-20^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2014169833-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2019051264-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2018039378-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2014169833-A9
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID8038
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID7958
http://rdf.ncbi.nlm.nih.gov/pubchem/anatomy/ANATOMYID1017
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID410994934
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID4275592
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID6375
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID284
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID6344
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419538410
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419484996
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID702
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419554492
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419559095
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226405837
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID426025815
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID7809
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID283
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID438957757
http://rdf.ncbi.nlm.nih.gov/pubchem/anatomy/ANATOMYID2298
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID7909
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226411656
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID407631466
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID6342
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID407631465
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419559502
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID155003199

Showing number of triples: 1 to 46 of 46.